Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Olatoyosi Odenike is a professor of medicine and the Director of the Leukemia Program at The University of Chicago Medicine. Her clinical focus lies in the treatment of leukemia, chronic myeloproliferative diseases, and myelodysplastic syndromes. Dr. Odenike is the principal investigator on a number of clinical trials investigating molecularly targeted agents with the ultimate goal of improving treatment options for patients with chronic leukemias and chronic myeloproliferative diseases. She attended medical school at the University of Ibadan followed by a residency at the University of Illinois and a fellowship at the University of Chicago Medicine. Dr. Odenike is board certified in internal medicine, oncology and pediatrics.